Onconetix, Inc. (ONCO)

0.6478 -0.11 (-14.36%) USD  |  NASDAQ  |  Sep 14, 13:59
More

Onconetix Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for ONCO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Quarterly Actual Revenue Data

View and export this data back to 2022. Start Trial.
Date Value
September 30, 2023 --
June 30, 2023 --
Date Value
March 31, 2023 --
December 31, 2022 --

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
BridgeBio Pharma, Inc. Upgrade
Aprea Therapeutics, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Anika Therapeutics, Inc. Upgrade